PENTIXAPHARM HOLDING N AG Capital Reinvestment Ratio

Latest as of December 2023: 2.32x

PENTIXAPHARM HOLDING N AG capital reinvestment ratio. PENTIXAPHARM HOLDING N AG (PTP) has a Capital Reinvestment Ratio of 2.32x as of December 2023, meaning it reinvests 2% of its operating cash flow (€2.13 Million) in capital expenditures (€4.94 Million). Check PENTIXAPHARM HOLDING N AG total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

2.32x
Capex / Operating Cash Flow

Operating Cash Flow

€2.13 Million
EUR

Capital Expenditures

€4.94 Million
EUR

Data as of

Dec 2023
Most recent filing

Capital Reinvestment Ratio of PENTIXAPHARM HOLDING N AG (2023–2023)

Capital reinvestment ratio of PENTIXAPHARM HOLDING N AG from 2023 to 2023. This chart tracks PENTIXAPHARM HOLDING N AG's Capital Reinvestment Ratio across 1 annual periods. Also explore PENTIXAPHARM HOLDING N AG (PTP) net asset momentum to track the company's year-over-year net asset growth rate.

PENTIXAPHARM HOLDING N AG Capital Reinvestment Ratio by Year (2023–2023)

PENTIXAPHARM HOLDING N AG capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see PENTIXAPHARM HOLDING N AG operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2023 2.32x €2.13 Million €4.94 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow